Compared to the people who got a placebo, those who received Ozempic said they drank fewer drinks at home. They also drank less in the lab at the trial’s end. A bonus: smokers smoked fewer cigarettes, too.

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name Ozempic — may help reduce not only alcohol cravings, but the amount of alcohol consumed when someone on the drug does drink